.
(A) Population histograms of autonomous firing frequency in vehicle-injected (black) versus 6-OHDA-injected (green) mice. (B, C) Representative trace (B) and population data (C) demonstrating that chronic SC administration of CNO (blue, as for the schedule in Fig. 2A ) in non DREADD-expressing C57BL/6 mice had no effect on the frequency, regularity, or incidence of autonomous STN activity relative to control data (illustrated in Figure 1D , E). ns, not significant. Table S4 .
(A, B) Inhibition of KATP channels with glibenclamide rescued the frequency and regularity of autonomous firing in slices from CNO-treated adora2A-rM3D(Gs)-mCherry mice but had minimal effects in slices from vehicletreated adora2A-rM3D(Gs)-mCherry mice (A, example; B, population data). Glibenclamide-associated changes in the frequency and regularity of firing are illustrated in B. * p < 0.05. Figure S3 . Inhibition of SK channels did not rescue autonomous activity in 6-OHDA-injected mice. Table S4 .
Relates to Figures 4 and S2 and
(A, B) Inhibition of SK channels with 10 nM apamin did not rescue the frequency and regularity of autonomous firing in slices from 6-OHDA-injected mice. Furthermore, the effects of SK channel inhibition were not significantly different in 6-OHDA-and vehicle-injected mice (A, example; B, population data). Apamin-associated changes in the frequency and regularity of firing are illustrated in B. ns, not significant. Figure S4 . Administration of CNO ex vivo had no effect on autonomous STN activity in brain slices prepared from non DREADD-expressing mice. Relates to Figure 5 and Table S5 .
Representative traces (A) and population data (B) demonstrating that application of 10 µM CNO to ex vivo brain slices prepared from non DREADD-expressing mice had no effect on the frequency or regularity of autonomous STN activity. ns, not significant. Figure S5 . Administration of CNO in vivo had no effect on forelimb use asymmetry in unilateral 6-OHDAlesioned, non DREADD-expressing mice. Relates to Figure 7 and Table S7 .
Administration of CNO (SC, 1 mg/kg) to 6-OHDA-injected, DA-depleted, non DREADD-expressing mice (n = 9) had no significant impact on their forelimb use. ns, not significant. 
